Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Sees Q4 Revenues Decline, Negotiates $2.75M Convertible Note

NEW YORK, Feb. 24 (GenomeWeb News) - Transgenomic today reported a 7 percent drop in fourth-quarter revenues year over year, coupled with narrowed net losses, lower R&D spending, and dwindling cash reserves.

The company's revenues for the fourth quarter ended Dec. 31, 2003, were $8.5 million, down from $9.2 million in the year-ago period.

Transgenomic's net loss for the quarter, including a goodwill impairment charge of $4.8 million, was $8.5 million, or $.32 per share. This was down from a net loss of $9.3 million, or $.40 per share, in the fourth quarter of 2002, which included restructuring charges of $3.3 million.

Transgenomic spent $2.2 million on R&D during the quarter, down 33 percent from $3.3 million in the fourth quarter of 2002.

The company had $1.2 million in cash, cash equivalents, and short-term investments as of Dec. 31, 2003, compared to $13.3 million at the close of 2002.

CFO Michael Draper said that the company has abandoned its previous plans to improve its liquidity position, which involved a sale-and-leaseback transaction related to its Glasgow, Scotland, manufacturing facility. Instead, the company will broaden a $7.5 million credit facility it established with Laurus Master Fund in December to include a three-year, $2.75 million convertible note. Draper said the arrangement "is preferable to the sale and leaseback options available" and "will be adequate to support our operations," based on current projections.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.